Healthcare M&A That Survives Diligence
We represent platforms, private equity sponsors, and lenders on healthcare M&A from initial platform investment through add-on acquisitions and exit. Our team brings deep healthcare regulatory knowledge to every transaction, ensuring that deals are structured to withstand both closing diligence and post-close scrutiny.
Due Diligence
Clinical, regulatory, payor, and operational diligence for healthcare acquisitions
Deal Structuring
Platform formation, recapitalizations, and growth equity structures
Integration
Post-close integration planning and regulatory harmonization
Value Creation
Acquisition playbooks and pipeline support for high-volume consolidators
How We De-Risk Your Deal
- Healthcare-specific diligence: Corporate practice compliance, payor contract review, licensing status, regulatory exposure, and operational risk assessment across all target states
- Deal documentation: Purchase agreements, rollover equity, earnout mechanics, working capital adjustments, and representations and warranties tailored to healthcare platform economics
- Regulatory pre-closing: State board notifications, change of ownership filings, payor contract assignments, and licensing transfer coordination
- Antitrust planning: HSR analysis, filing strategy, and merger clearance support for consolidating platforms
- Post-close integration: Transition services agreements, employment matters, real estate assignments, and regulatory harmonization across acquired locations
Transaction Types
- Platform investments: Initial private equity investments, management buyouts, and growth equity for emerging platforms
- Add-on acquisitions: High-volume add-on programs with standardized diligence, documentation, and integration playbooks
- Recapitalizations: Secondary buyouts, dividend recaps, and sponsor-to-sponsor transactions
- Exit transactions: Full business sales, carve-outs, and IPO preparation for healthcare platforms
- De novo programs: New location development, joint venture structures, and management company formations
Corporate / M&A Team
R. Craig Woods, Virgil Ochoa, Eric White, Dean Gould, and Evan Atkinson, supported by regulatory, finance, and employment specialists.
Why Healthcare M&A Requires Specialized Counsel
Healthcare M&A is not standard commercial M&A with a regulatory overlay. Corporate practice doctrine, fee-splitting restrictions, licensing requirements, and payor contract issues can materially affect deal value, deal structure, and the ability to close. Buyers who learn about these issues post-close face integration challenges, regulatory exposure, and valuation disputes. We identify these issues early, structure transactions to address them, and prepare clients for what comes after closing.
Ready to Start Your Transaction?
Our team is ready to help you structure, diligence, and close your next healthcare M&A transaction.
Start Your Journey